Smart Lipo capsules are being recalled because they contain unapproved drugs that are not declared on the label. Consumers who have purchased this product should not use it as the unapproved drugs pose a significant health risk.
The 800 and 900 mg capsules of Smart Lipo contain sibutramine, desmethylsibutramine, and phenolphthalein. Sibutramine, an appetite suppressant, was withdrawn from the market in 2010 after it was found to cause significant health risk to patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. Phenolphthalein, a laxative, was withdrawn from the market due to concerns that it may cause gastrointestinal disturbances, irregular heartbeat, and cancer.
These undeclared ingredients pose risk on their own but mat also cause a life-threatening interaction with other medications.
The recalled product was marketed as a dietary supplement and was sold in bottles of 30 capsules with the following expiration dates: 800mg capsules – 9/15/2017, 900mg capsules – 7/30/2017, 950mg capsules – 7/30/2017 and 7/30/2018. Smart Lipo was sold in stores, Centro Naturista in Richardson, TX, SmartLipo365 in Arlington, TX, as well as through online sales.
